Do magnesium, vitamin B12, zinc, and vitamin D support estrogen metabolism and hormone-fluctuation resilience?

Clinical evidence

• Premenstrual symptom mitigation: Clinical trials and meta-analyses show that correcting deficiencies in magnesium, zinc, and vitamin D significantly improves tolerance to cyclical hormonal shifts. Randomized controlled trials (RCTs) evaluating magnesium supplementation (200–360 mg/day elemental magnesium) demonstrate significant reductions in fluid retention, bloating, and mood-related symptoms within two menstrual cycles.
• Mood and physical support: Zinc supplementation (30–50 mg/day for 1 to 3 months) consistently improves premenstrual emotional symptoms—including anger, anxiety, and depression—alongside physical symptom scores. Correcting vitamin D deficiency likewise reduces total premenstrual syndrome (PMS) severity and depressive mood.
• Synergistic formulation impact: While isolated clinical data for vitamin B12's individual impact on hormonal resilience are limited, B12 is highly effective when utilized in broad-spectrum micronutrient formulas, which show high clinical remission rates for premenstrual physical and psychological distress.

Mechanistic explanations

• Estrogen clearance and COMT activation: Magnesium acts as an obligatory, direct cofactor for catechol-O-methyltransferase (COMT), the primary Phase II enzyme that methylates reactive catechol estrogens into stable, excretable forms. Structurally, magnesium binds to the COMT active site and lowers the pKa of catechol hydroxyl groups, facilitating the transfer of a methyl group from S-adenosylmethionine (SAMe).
• One-carbon cycle and SAMe synthesis: Vitamin B12 and zinc are absolute biochemical prerequisites for methionine synthase (MTR), which links the folate and methionine cycles. Zinc coordinates and activates the substrate homocysteine, while vitamin B12 acts as an organometallic methyl shuttle to regenerate methionine, sustaining the SAMe pool required for COMT-mediated estrogen clearance.
• Auxiliary methylation pathways: Vitamin D supports methylation pathways by transcriptionally up-regulating the reduced folate carrier (RFC) to enhance folate uptake and stimulating cystathionine $\beta$-synthase (CBS) to clear homocysteine, optimizing the SAMe to S-adenosylhomocysteine (SAH) ratio.
• Immune modulation and tolerance: Vitamin D directly regulates immune tolerance via the Th17/Treg axis by suppressing pro-inflammatory Th17 responses, driving regulatory T cell (Treg) differentiation, and promoting TGF-$\beta$ expression. Magnesium is critical for the enzymatic activation and signaling of vitamin D, while zinc and vitamin B12 act as essential metabolic cofactors supporting overall immune homeostasis.

Bottom line

An abundance of biochemical and clinical evidence supports the claim. Magnesium and vitamin B12 directly drive Phase II COMT estrogen methylation and overall one-carbon metabolism, while vitamin D and zinc modulate systemic immune tolerance and endocrine pathways. Insufficiencies in these nutrients directly compromise enzymatic clearance and reduce clinical resilience to normal cyclical hormonal fluctuations.